Company
Ottobock
Ottobock is a German medical device company developing robotic prosthetics, including the C-Leg bionic knee, bebionic hand, and exoskeleton systems for…
- Founded
- 1919
- HQ
- Duderstadt, Germany
- Status
- private (family-owned; Naeder Holding)
Models
1
Overview
Ottobock is a German medical device company developing robotic prosthetics, including the C-Leg bionic knee, bebionic hand, and exoskeleton systems for rehabilitation. The world leader in prosthetics.
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
DEPLOY Intelligence
Market intelligence for physical AI
Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.
Key facts
Focus
German prosthetics and orthotics group
Acquisition
Acquired exoskeleton maker SuitX in 2021
Robot
Phoenix lower-limb powered exoskeleton derived from SuitX
Technology
Paexo industrial line is passive spring-based; Phoenix is the powered device
Product
C-Brace, Paexo exoskeletons, Phoenix (SuitX)
Acquired
suitX (100% shares)
Applications
Prosthetics, orthotics, occupational exoskeletons
Data & sources
Web sources
2
2 sources backing this record.View all →
Models (1)
View all models →Explainers
Plain-language answers to the questions people ask about Ottobock, from DEPLOY’s explainer library. Each is written in the language of the question and cross-checked against this registry.
- What is an exoskeleton robot and how does it work?
An exoskeleton is a powered wearable robotic device worn by a human that assists or amplifies the wearer's movement. Exoskeletons are not autonomous robots: the wearer's intent drives every action. The category divides between medical exoskeletons (FDA-cleared for rehabilitation and personal mobility) and industrial exoskeletons (worn by workers to reduce fatigue and injury risk).
- What is Ottobock Paexo and how does it help workers?
Ottobock is a German prosthetics and orthotics leader that makes the Paexo series of industrial exoskeletons for manufacturing and logistics workers. Paexo models target overhead work (Paexo Shoulder), lower back strain (Paexo Trunk), and neck fatigue (Paexo Cervical). Ottobock also acquired SuitX in 2021. The company is a privately held German firm.
Safety record
No incidents on record for Ottobock.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Peer companies
- Honda3 models
- Ekso Bionics2 models
- German Bionic2 models
- Lifeward2 models
- ATOUN1 model
- B-TEMIA1 model
Financial state
- Reporting basis
- private_reported
- Lifecycle stage
- mature
- Counterparty risk class
- low
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Sources (2)
Common questions
- What is Ottobock?
- Ottobock is a German medical device company developing robotic prosthetics, including the C-Leg bionic knee, bebionic hand, and exoskeleton systems for rehabilitation. The world leader in prosthetics.
- What does Ottobock make?
- Ottobock has 1 robot model on the DEPLOY registry: Ottobock Phoenix (SuitX) (Ottobock builds physical robots).
- Is Ottobock publicly traded?
- Ottobock is not an independent public company; it has been acquired, per the DEPLOY registry.
- Who competes with Ottobock?
- On the DEPLOY registry, peer companies to Ottobock building in the same form factors include Honda, Ekso Bionics, German Bionic, Lifeward.
- Where is Ottobock headquartered?
- Ottobock is headquartered in Duderstadt, Germany.
- Where does Ottobock operate robots?
- Ottobock is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.
- Is Ottobock a top robotics company?
- On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Ottobock ranks in roughly the top 31% of companies tracked by the registry.
- When was Ottobock founded?
- Ottobock was founded in 1919.
- Is Ottobock safe?
- Ottobock has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 2 sources (no primary) · last reviewed 2026-07-07
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-07-07
Sources by quality tier
- 1
- knowledge-base
- Knowledge base
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Ottobock.Peer companies
- Honda3 models
- Ekso Bionics2 models
- German Bionic2 models
- Lifeward2 models
- ATOUN1 model
- B-TEMIA1 model
Machine-readable surfaces
- Markdown mirror: /companies/ottobock.md
- RSS feed: /companies/ottobock/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/135e1e83-1345-4fee-b258-e349b065345d
- Revision history: /companies/ottobock/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Honda3 models
- Ekso Bionics2 models
- German Bionic2 models
- Lifeward2 models
- ATOUN1 model
- B-TEMIA1 model
Reality vs attention
Ottobock draws attention at the 24th percentile but verifies reality at the 35th percentile among exoskeletons. Hype Gap -11, 5th widest among exoskeletons.
Analysis
Clean safety record across 1 verified deployment. Limited public visibility and press coverage relative to peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Jul 14, 2026